Yung-Chin Hsiao

Yung-Chin Hsiao (蕭永晉)

Appointment : Assistant Professor

Lab：Proteomic translational medicine Laboratory

Education : Ph.D.

University/Nation：Chung Shan Medical University/R.O.C

Tel: 3552

E-mail : hschin@mail.cgu.edu.tw

Research website :

Research interests:

In the post-genomic era, many advanced technologies have been developed for the proteomic approaches after the whole genome sequencing completed. Our researches focus on the differentially expressed proteins discovered in biological samples by using advanced quantitative proteomic approaches. We are trying to explore the particular proteins involved in the early detection, therapeutic target, and prognosis in tumors.

Assay development: 1) We have developed a multiplexed and quantitative platform that combines immuno-affinity enrichment and mass spectrometry, known as “SISCAPA-MRM” (stable isotope standards with capture by anti-peptide antibodies coupled with multiple reaction monitoring) or “immuno-MRM”, and further applied these assays to quantify dozens of low abundant protein targets in saliva and serum/plasma samples. 2) we also established the platform of systematic evolution of ligands by exponential enrichment (SELEX) to generate the target-specific DNA/RNA aptamer, single stranded DNA/RNA specifically bind to target, and will further develop aptamer-based assays for cancer detection.

Oral cancer study: Using MRM and immuno-MRM technologies, we verified a panel of protein biomarkers that capable to discriminate OSCC patient from health. Additionally, we illustrated the personal variations and diurnal fluctuations of salivary proteins and demonstrated the clinical utility of potential candidates in saliva rather than serum/plasma sample. Our study offers a practical foundation for using salivary protein biomarker panel to enable early detection of OSCC.

Tumor immunologic study: To explore the role of immune system in tumorigenesis and progression, the studies include several domains: 1) the carcinogenic mechanism involved in chronic inflammation; 2) the interactions between tumor cells and immune cells: 3) applications of tumor immunology in treatment, monitoring, and anti-cancer vaccine.

Publications (Recent 5 years):

  1. Liu CC, Yang YH, Hsiao YC, Wang PJ, Liu JC, Liu CH, Hsieh WC, Lin CC, and Yu JS. Rapid and Efficient Enrichment of Snake Venoms from Human Plasma Using a Strong Cation Exchange Tip Column to Improve Snakebite Diagnosis. Toxins (Basel) 2021, 13 (2)Toxins
  2. Liu CC, Wu CJ, Hsiao YC, Yang YH, Liu KL, Huang GJ, Hsieh CH, Chen CK, and Liaw GW. Snake venom proteome of Protobothrops mucrosquamatus in Taiwan: Delaying venom-induced lethality in a rodent model by inhibition of phospholipase A2 activity with varespladib. J Proteomics 2020, 234, 104084.
  3. Lin YH, Wu CC, Su WT, Tseng PC, Hsueh YY, Hsiao YC, Chang KP, Yu JS, and Chuang YJ. Target peptide enrichment microfluidic chip for rapid detection of oral squamous cell carcinoma using stable isotope standards and capture by anti-peptide antibodies. Sensors and Actuators B: Chemical 2020, 322, 128607.
  4. Hsiao YC, Lin SY, Chien KY, Chen SF, Wu CC, Chang YT, Chi LM, Chu LJ, Chiang WF, Chien CY, Chang KP, Chang YS, and Yu JS. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. Anal Chim Acta 2020, 1100, 118-130.
  5. Chi LM#, Hsiao YC#, Chien KY#, Chen SF, Chuang YN, Lin SY, Wang WS, Chang IY, Yang C, Chu LJ, Chiang WF, Chien CY, Chang YS, Chang KP, and Yu JS. Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry. J Proteomics 2020, 211, 103571.
  6. Liu CC, Yu JS, Wang PJ, Hsiao YC, Liu CH, Chen YC, Lai PF, Hsu CP, Fann WC, and Lin CC. Development of sandwich ELISA and lateral flow strip assays for diagnosing clinically significant snakebite in Taiwan. PLoS Negl Trop Dis 2018, 12 (12), e0007014.
  7. Liu CC, Lin CC, Hsiao YC, Wang PJ, and Yu JS. Proteomic characterization of six Taiwanese snake venoms: Identification of species-specific proteins and development of a SISCAPA-MRM assay for cobra venom factors. J Proteomics 2018, 187, 59-68.
  8. Hsiao YC, Chu LJ, Chen YT, Chi LM, Chien KY, Chiang WF, Chang YT, Chen SF, Wang WS, Chuang YN, Lin SY, Chien CY, Chang KP, Chang YS, and Yu JS. Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry. Proteomics Clin Appl 2018, 12 (2)
  9. Hsiao YC, Chu LJ, Chen JT, Yeh TS, and Yu JS. Proteomic profiling of the cancer cell secretome: informing clinical research. Expert Rev Proteomics 2017, 14 (9), 737-756.
  10. Hsiao YC, Chi LM, Chien KY, Chiang WF, Chen SF, Chuang YN, Lin SY, Wu CC, Chang YT, Chu LJ, Chen YT, Chia SL, Chien CY, Chang KP, Chang YS, and Yu JS. Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry. Mol Cell Proteomics 2017, 16 (10), 1829-1849.
  11. Yu JS#, Chen YT#, Chiang WF#, Hsiao YC#, Chu LJ#, See LC, Wu CS, Tu HT, Chen HW, Chen CC, Liao WC, Chang YT, Wu CC, Lin CY, Liu SY, Chiou ST, Chia SL, Chang KP, Chien CY, Chang SW, Chang CJ, Young JD, Pao CC, Chang YS, and Hartwell LH. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Proc Natl Acad Sci U S A 2016, 113 (41), 11549-11554.
  12. Chen H#, Hsiao YC#, Chiang SF, Wu CC, Lin YT, Liu H, Zhao H, Chen JS, Chang YS, and Yu JS. Quantitative analysis of wild-type and V600E mutant BRAF proteins in colorectal carcinoma using immunoenrichment and targeted mass spectrometry. Anal Chim Acta 2016, 933, 144-155.